Theravance Biopharma Q4 Loss Widens Y/Y, Revenues Up By: TalkMarkets March 11, 2015 at 11:47 AM EDT Theravance Biopharma, Inc. reported fourth-quarter 2014 loss of $2.02 per share, wider than a loss of $1.39 per share incurred a year ago. Read More >> Related Stocks: Cytokinetics Gsk Plc ADR Theravance Bio Ord